IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL - ANVISA Registration 10287411680

Access comprehensive regulatory information for IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10287411680 and manufactured by manufacturer not specified. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until Dec 26, 2033.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including VENTANA MEDICAL SYSTEM, INC, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10287411680
2 Related Devices
Registration Details
ANVISA Registration Number: 10287411680
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

VENTANA PTEN (SP218) Rabbit Monoclonal Primary Antibody
Risk Class III

Registration Details

10287411680

25351571727202312

30280358000186

Company Information

Dates and Status

Dec 26, 2023

26/12/2033

09/18/2025 19:00:01

VENTANA PTEN (SP218) Rabbit Monoclonal Primary Antibody
Risk Class III

Registration Details

10287411680

25351571727202312

30280358000186

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Dec 26, 2023

26/12/2033

09/18/2025 19:00:01